[(4-Heptyl-phenylamino)-phosphono-methyl]-phosphonic acid

ID: ALA433833

PubChem CID: 5277463

Max Phase: Preclinical

Molecular Formula: C14H25NO6P2

Molecular Weight: 365.30

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCc1ccc(NC(P(=O)(O)O)P(=O)(O)O)cc1

Standard InChI:  InChI=1S/C14H25NO6P2/c1-2-3-4-5-6-7-12-8-10-13(11-9-12)15-14(22(16,17)18)23(19,20)21/h8-11,14-15H,2-7H2,1H3,(H2,16,17,18)(H2,19,20,21)

Standard InChI Key:  IGHWTRWWSFAETJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 23  0  0  0  0  0  0  0  0999 V2000
   15.7101  -14.8490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7089  -15.6763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4236  -16.0892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1401  -15.6759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1372  -14.8453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4218  -14.4363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8583  -14.4262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.8554  -13.5971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1389  -13.1826    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   18.5679  -13.1827    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   19.2897  -12.7686    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.4193  -12.7687    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.5552  -12.4618    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7213  -13.9034    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.9831  -13.9034    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.5613  -12.3575    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.9939  -16.0921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2783  -15.6819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5651  -16.0967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8494  -15.6865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1363  -16.1012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4206  -15.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7074  -16.1058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  6  2  0
  9 12  2  0
  6  1  1  0
  9 13  1  0
  1  2  2  0
  9 14  1  0
  5  7  1  0
 10 15  1  0
  3  4  2  0
 10 16  1  0
  7  8  1  0
  2 17  1  0
 17 18  1  0
  8  9  1  0
 18 19  1  0
  4  5  1  0
 19 20  1  0
  8 10  1  0
 20 21  1  0
  2  3  1  0
 21 22  1  0
 10 11  2  0
 22 23  1  0
M  END

Alternative Forms

Associated Targets(Human)

KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Entamoeba histolytica (2676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Farnesyl pyrophosphate synthase (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HK Hexokinase (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dictyostelium discoideum (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 365.30Molecular Weight (Monoisotopic): 365.1157AlogP: 3.25#Rotatable Bonds: 10
Polar Surface Area: 127.09Molecular Species: ACIDHBA: 3HBD: 5
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 0.95CX Basic pKa: CX LogP: 3.09CX LogD: -1.74
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.32Np Likeness Score: -0.05

References

1. Ghosh S, Chan JM, Lea CR, Meints GA, Lewis JC, Tovian ZS, Flessner RM, Loftus TC, Bruchhaus I, Kendrick H, Croft SL, Kemp RG, Kobayashi S, Nozaki T, Oldfield E..  (2004)  Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo.,  47  (1): [PMID:14695831] [10.1021/jm030084x]
2. Hudock MP, Sanz-Rodríguez CE, Song Y, Chan JM, Zhang Y, Odeh S, Kosztowski T, Leon-Rossell A, Concepción JL, Yardley V, Croft SL, Urbina JA, Oldfield E..  (2006)  Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates.,  49  (1): [PMID:16392806] [10.1021/jm0582625]
3. Leon A, Liu L, Yang Y, Hudock MP, Hall P, Yin F, Studer D, Puan KJ, Morita CT, Oldfield E..  (2006)  Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.,  49  (25): [PMID:17149863] [10.1021/jm060492b]
4. Sanz-Rodríguez CE, Concepción JL, Pekerar S, Oldfield E, Urbina JA..  (2007)  Bisphosphonates as inhibitors of Trypanosoma cruzi hexokinase: kinetic and metabolic studies.,  282  (17): [PMID:17329254] [10.1074/jbc.m607286200]
5. Song Y, Chan JM, Tovian Z, Secrest A, Nagy E, Krysiak K, Bergan K, Parniak MA, Oldfield E..  (2008)  Bisphosphonate inhibitors of ATP-mediated HIV-1 reverse transcriptase catalyzed excision of chain-terminating 3'-azido, 3'-deoxythymidine: a QSAR investigation.,  16  (19): [PMID:18789701] [10.1016/j.bmc.2008.08.047]

Source